Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LivaNova (LIVN) Research & Development (2016 - 2025)

LivaNova (LIVN) has disclosed Research & Development for 12 consecutive years, with $52.1 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 20.35% to $52.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $185.8 million through Dec 2025, up 1.78% year-over-year, with the annual reading at $185.8 million for FY2025, 1.78% up from the prior year.
  • Research & Development hit $52.1 million in Q4 2025 for LivaNova, up from $48.6 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $52.6 million in Q2 2021 to a low of $34.2 million in Q2 2022.
  • Historically, Research & Development has averaged $45.1 million across 5 years, with a median of $45.3 million in 2022.
  • Biggest five-year swings in Research & Development: surged 108.96% in 2021 and later tumbled 34.87% in 2022.
  • Year by year, Research & Development stood at $44.1 million in 2021, then increased by 1.89% to $44.9 million in 2022, then grew by 2.74% to $46.2 million in 2023, then dropped by 6.19% to $43.3 million in 2024, then grew by 20.35% to $52.1 million in 2025.
  • Business Quant data shows Research & Development for LIVN at $52.1 million in Q4 2025, $48.6 million in Q3 2025, and $47.2 million in Q2 2025.